Skip to content
OpenCapital
Get started

Schrodinger SDGR Net investment gains (losses)

Net investment gains (losses) at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
——

Other financials

Income statement

See full
Revenue$58.6M-1.6%
Gross profit$29.5M-5.1%
Operating income-$48.8M+4.1%
Net income-$60.0M-0.4%
EPS (diluted)-$0.81+1.2%

Balance sheet

See full
Cash & equivalents$267.7M-20.7%
Total debt$107.0M-7.9%
Total equity$313.5M-16.1%
Total assets$634.2M-14.6%

Cash flow

See full
Operating cash flow-$14.8M-110%
CapEx$2.5M+321%
Free cash flow-$17.3M-112%

Valuation

See full
Market cap$1.15B-19.7%
Enterprise value$984.71M-18.3%
P/S4.5×-1.7×

Profitability

See full
Gross margin55.3%-7.3pp
Operating margin-64.7%-12.0pp
Net margin-68.5%—
FCF margin9.6%+5.1pp

Returns & leverage

See full
Return on equity-45.7%—
Debt / equity0.3×0.0×
Current ratio2.7×-0.7×

Where this comes from

Reported directly by Schrodinger in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesFvNiGainLoss.

The official record: Schrodinger’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Schrodinger's net investment gains (losses).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Schrodinger's net investment gains (losses)?
Schrodinger (SDGR) reported net investment gains (losses) of -$13.49M in Q1 2026.
How has Schrodinger's net investment gains (losses) changed year-over-year?
Schrodinger's net investment gains (losses) decreased by 3.0% year-over-year, from -$13.1M to -$13.49M.
What is the long-term trend for Schrodinger's net investment gains (losses)?
Over 3 years (2021 to 2025), Schrodinger's net investment gains (losses) has grown at a 61.9% compound annual growth rate (CAGR), from $11.36M to $48.17M.
What does net investment gains (losses) mean?
Net realized and unrealized gains and losses on the company's investment portfolio, including equity securities, debt securities, and alternative investments.